95 related articles for article (PubMed ID: 25531992)
1. TIMP-1: a strong player in colorectal cancer.
Herszényi L
J Gastrointestin Liver Dis; 2014 Dec; 23(4):365-6. PubMed ID: 25531992
[No Abstract] [Full Text] [Related]
2. TIMP-1 expression in human colorectal cancer is associated with SMAD3 gene expression levels: a pilot study.
Ionescu C; Braicu C; Chiorean R; Cojocneanu Petric R; Neagoe E; Pop L; Chira S; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2014 Dec; 23(4):413-8. PubMed ID: 25532000
[TBL] [Abstract][Full Text] [Related]
3. A TIMP-1 splice variant transcript: possible role in regulation of TIMP-1 expression.
Obro NF; Lademann U; Birkenkamp-Demtroder K; Holten-Andersen L; Brünner N; Offenberg H
Cancer Lett; 2008 Apr; 262(1):64-70. PubMed ID: 18180096
[TBL] [Abstract][Full Text] [Related]
4. Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma.
Holten-Andersen MN; Hansen U; Brünner N; Nielsen HJ; Illemann M; Nielsen BS
Int J Cancer; 2005 Jan; 113(2):198-206. PubMed ID: 15386409
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of tissue inhibitor of metalloproteinase-1 gene correlates with poor outcomes in colorectal cancer.
Inagaki D; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Yamada T; Yamamoto N; Sato T; Shiozawa M; Morinaga S; Akaike M; Fujii S; Numata K; Kunisaki C; Rino Y; Tanaka K; Masuda M; Imada T
Anticancer Res; 2010 Oct; 30(10):4127-30. PubMed ID: 21036730
[TBL] [Abstract][Full Text] [Related]
6. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.
Spindler KL; Christensen IJ; Nielsen HJ; Jakobsen A; Brünner N
Tumour Biol; 2015 Jun; 36(6):4301-8. PubMed ID: 25608838
[TBL] [Abstract][Full Text] [Related]
7. TUC.338 promotes invasion and metastasis in colorectal cancer.
Wang C; Wang Z; Zhou J; Liu S; Wu C; Huang C; Ding Y
Int J Cancer; 2017 Mar; 140(6):1457-1464. PubMed ID: 27914101
[TBL] [Abstract][Full Text] [Related]
8. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
[TBL] [Abstract][Full Text] [Related]
9. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
[TBL] [Abstract][Full Text] [Related]
10. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
Sutnar A; Pesta M; Liska V; Treska V; Skalicky T; Kormunda S; Topolcan O; Cerny R; Holubec L
Tumour Biol; 2007; 28(5):247-52. PubMed ID: 17992052
[TBL] [Abstract][Full Text] [Related]
12. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
[TBL] [Abstract][Full Text] [Related]
13. TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.
Tarpgaard LS; Ørum-Madsen MS; Christensen IJ; Nordgaard C; Noer J; Guren TK; Glimelius B; Sorbye H; Ikdahl T; Kure EH; Tveit KM; Nielsen HJ; Pfeiffer P; Brünner N; Moreira JM
Oncotarget; 2016 Sep; 7(37):59441-59457. PubMed ID: 27509063
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.
Hilska M; Roberts PJ; Collan YU; Laine VJ; Kössi J; Hirsimäki P; Rahkonen O; Laato M
Int J Cancer; 2007 Aug; 121(4):714-23. PubMed ID: 17455256
[TBL] [Abstract][Full Text] [Related]
15. Effects of various treatment approaches for treatment efficacy for late stage breast cancer and expression level of TIMP-1 and MMP-9.
Yuan J; Xiao C; Lu H; Yu H; Hong H; Guo C; Wu Z
Cancer Biomark; 2018; 23(1):1-7. PubMed ID: 30010105
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
[TBL] [Abstract][Full Text] [Related]
17. [Smad3-/- mice: a murine model for the study of human colorectal cancers?].
Vignais ML
Bull Cancer; 1998 Dec; 85(12):989-90. PubMed ID: 9988554
[No Abstract] [Full Text] [Related]
18. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
[TBL] [Abstract][Full Text] [Related]
19. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.
Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2014 Aug; 52(8):1217-27. PubMed ID: 24615484
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
